Trial · NCT01974440
Adverse events610
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 610
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Placebo + Chemoimmunotherapy (CIT) | 39 | 199 | |
| other | Anaemia | Blood and lymphatic system disorders | Ibrutinib + CIT | 50 | 201 | |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo + Chemoimmunotherapy (CIT) | 26 | 199 | |
| other | Leukopenia | Blood and lymphatic system disorders | Ibrutinib + CIT | 27 | 201 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Placebo + Chemoimmunotherapy (CIT) | 23 | 199 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Ibrutinib + CIT | 18 | 201 | |
| other | Neutropenia | Blood and lymphatic system disorders | Placebo + Chemoimmunotherapy (CIT) | 69 | 199 | |
| other | Neutropenia | Blood and lymphatic system disorders | Ibrutinib + CIT | 75 | 201 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo + Chemoimmunotherapy (CIT) | 28 | 199 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Ibrutinib + CIT | 46 | 201 | |
| other | Atrial Fibrillation | Cardiac disorders | Placebo + Chemoimmunotherapy (CIT) | 5 | 199 | |
| other | Atrial Fibrillation | Cardiac disorders | Ibrutinib + CIT | 12 | 201 | |
| other | Vertigo | Ear and labyrinth disorders | Placebo + Chemoimmunotherapy (CIT) | 15 | 199 | |
| other | Vertigo | Ear and labyrinth disorders | Ibrutinib + CIT | 12 | 201 | |
| other | Abdominal Pain | Gastrointestinal disorders | Placebo + Chemoimmunotherapy (CIT) | 18 | 199 | |
| other | Abdominal Pain | Gastrointestinal disorders | Ibrutinib + CIT | 16 | 201 | |
| other | Abdominal Pain Upper | Gastrointestinal disorders | Placebo + Chemoimmunotherapy (CIT) | 13 | 199 | |
| other | Abdominal Pain Upper | Gastrointestinal disorders | Ibrutinib + CIT | 19 | 201 | |
| other | Constipation | Gastrointestinal disorders | Placebo + Chemoimmunotherapy (CIT) | 54 | 199 | |
| other | Constipation | Gastrointestinal disorders | Ibrutinib + CIT | 33 | 201 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01974440/events